| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
2 companies
Jovan-Embiricos Morana is a 10% Owner at Cullinan Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 14 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 800 | $24.77 | $19,812.00 | - | -65.8% | -66.4% | |
| Nov 9, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 12,196 | $24.80 | $302,455.17 | -0.4% | -66.7% | -71.2% | |
| Oct 27, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 2,200 | $24.78 | $54,510.50 | -0.1% | -66.0% | -73.4% | |
| Oct 25, 2021 | KLRS Kalaris Therapeutics, Inc. | Director | Sell | 13,592 | $24.80 | $337,045.37 | -0.3% | -66.5% | -72.0% | |
| Jan 12, 2021 | CGEM Cullinan Therapeutics, Inc. | Director, 10% Owner | Buy | 200,000 | $21.00 | $4,200,000.00 | +38.0% | - | - | |
| Aug 3, 2020 | KLRS Kalaris Therapeutics, Inc. | Director, 10% Owner | Buy | 2,900,000 | $17.00 | $49,300,000.00 | +1,174% | - | - |